Abstract
The increase in cases of diabetes mellitus type 2 in Brazil in the last decade encourages the search for new drugs to fight it. There are more than 400 million people affected by that disease around the world. The illness is characterized especially by the excess of glucose in the blood and irregular secretion of insulin. Rosiglitazone (Avandia ®), was the first drug from the glitazone cl…